Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01545336 · ClinicalTrials.gov registry record · Phase 2

Anastrozole in Patients With Pulmonary Arterial Hypertension

A Phase 2 study of Pulmonary Arterial Hypertension, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 2
Development phase
18
Enrollment target
3
Study locations

NCT01545336 is a Phase 2 study of Pulmonary Arterial Hypertension that has completed, run by University of Pennsylvania. The registered enrollment target is 18 participants, below the 462-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01545336, a Phase 2 study of Pulmonary Arterial Hypertension, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 2
Development phase
18 participants
Enrollment target
3
Study locations

Study Summary

The main purpose of this clinical trial is to study the safety and efficacy of anastrozole in adults diagnosed with pulmonary arterial hypertension (PAH). The study will evaluate how well the drug is tolerated. The study will also evaluate if anastrozole effects estradiol (E2) hormone levels, a sex hormone, and improves the function of the lower right chamber of the heart (right ventricle).

Conditions Studied

Pulmonary Arterial Hypertension

Interventions

  • DRUG Placebo
  • DRUG Anastrozole

Study Locations (3)

Pennsylvania

  • University of Pennsylvania - Penn Presbyterian - Philadelphia
  • University of Pennsylvania - Perelman Center - Philadelphia

Rhode Island

  • Brown University - Rhode Island Hospital - Providence

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2012-10
Est. Completion 2015-09
Phase Phase 2

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01545336

The ClinicalTrials.gov registry entry for NCT01545336 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 462-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (96% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01545336 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01545336 about?

NCT01545336 is a clinical study titled "Anastrozole in Patients With Pulmonary Arterial Hypertension". The main purpose of this clinical trial is to study the safety and efficacy of anastrozole in adults diagnosed with pulmonary arterial hypertension (PAH). The study will evaluate how well the drug is tolerated. The study will also evaluate if anastrozole effects estradiol (E2) hormone levels, a sex ...

What is the current status of trial NCT01545336?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2012-10. Estimated completion is 2015-09.

What conditions does trial NCT01545336 study?

This clinical trial studies the following conditions: Pulmonary Arterial Hypertension.

What interventions are being tested in trial NCT01545336?

The interventions under investigation include: Placebo (DRUG), Anastrozole (DRUG).

Who is sponsoring clinical trial NCT01545336?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01545336 being conducted?

This trial has 3 study locations across Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pulmonary Arterial Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pulmonary Arterial Hypertension

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.